MX9102702A - ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES. - Google Patents

ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.

Info

Publication number
MX9102702A
MX9102702A MX9102702A MX9102702A MX9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A
Authority
MX
Mexico
Prior art keywords
interfered
proliferative
lung diseases
oral inhalation
treat asthma
Prior art date
Application number
MX9102702A
Other languages
Spanish (es)
Inventor
Robert J Spiegel
Francis M Cuss
Keith B Nolop
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9102702A publication Critical patent/MX9102702A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX9102702A 1990-12-21 1991-12-19 ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES. MX9102702A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63155290A 1990-12-21 1990-12-21
US63156590A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
MX9102702A true MX9102702A (en) 1992-06-01

Family

ID=27091422

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102702A MX9102702A (en) 1990-12-21 1991-12-19 ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.

Country Status (6)

Country Link
AU (1) AU9132091A (en)
IE (1) IE914444A1 (en)
IL (1) IL100415A0 (en)
MX (1) MX9102702A (en)
PT (1) PT99837A (en)
WO (1) WO1992011025A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001502666A (en) 1996-09-12 2001-02-27 ジェネメディシン，インコーポレイテッド Compositions and methods for pulmonary gene delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
CA1295243C (en) * 1986-05-27 1992-02-04 Daniel J. Tanner Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
CA1297788C (en) * 1986-10-22 1992-03-24 Judith Feinberg Treatment of aids virus with recombinant human alpha interferon
EP0294160A1 (en) * 1987-06-02 1988-12-07 Schering Corporation Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
EP0351974A1 (en) * 1988-07-05 1990-01-24 Schering Corporation Treatment of genital warts with a combination of podophyllin and recombinant DNA human alpha interferon
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
EP0372809B1 (en) * 1988-12-01 1993-08-04 Schering Corporation Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
IE914444A1 (en) 1992-07-01
PT99837A (en) 1992-12-31
AU9132091A (en) 1992-07-22
WO1992011025A3 (en) 1992-09-17
WO1992011025A2 (en) 1992-07-09
IL100415A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
DK479189D0 (en) INHALER
TR199501635A1 (en) Therapeutic preparations taken by inhalation.
NO921110D0 (en) inhaler
DE59000161D1 (en) RESPIRATORY MASK.
DE3888838D1 (en) RESPIRATORY MASK.
DE69528237D1 (en) INHALER
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
ZA825222B (en) Spray dried inhalation drugs
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
FI915543A7 (en) POWDER INHALER.
EP0050654A4 (en) Inhalation spirometric device for administering pulmonary medication.
DE3369682D1 (en) 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments
NO893062L (en) USE OF ISOKINOLIC COMPOUNDS, SPECIFICALLY INHALATION PREPARATIONS.
FI823740A7 (en) Disposable respirator half mask.
ATE271852T1 (en) IMPROVED INHALATION PREPARATIONS
IL65184A (en) Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
MX9102702A (en) ALPHA ADMINISTRATION INTERFERED THROUGH ORAL INHALATION TO TREAT ASTHMA AND PROLIFERATIVE, NON-MALIGNANT LUNG DISEASES.
ZA816417B (en) Pharmaceutical composition,especially for treating infectious diseases of the respiratory tract
DE59203456D1 (en) Liposomes containing volatile inhalation anesthetics, their preparation and use.
MX9102512A (en) ORAL ADMINISTRATION OF ALPHA INTERFERON IN THE TREATMENT OF LUNG DISEASES.
DE3865818D1 (en) MEDICINAL PREPARATION FOR INHALATION APPLICATIONS.
FI821288A7 (en) Phenethanolamine derivatives, their preparation and their therapeutic use.
FI963753L (en) New drug to treat respiratory viral disease
JPS57176950A (en) Novel carnitine derivative, manufacture and remedy for burn, epythelial disease and respiratory disease
ITFI920029U1 (en) INHALER TO ADD AIR TO INSPIRE, FOR USE IN THE PRESENCE OF HARMFUL ATMOSPHERES.